Browsing by Author Simoons, Maarten L.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2009The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trialsChalmers, John; MacMahon, Stephen; Ninomiya, Toshiharu; Bertrand, Michel; Boersma, Eric; Brugts, Jasper; Ferrari, Roberto; Fox, Kim; Remme, Willem; Simoons, Maarten L.; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthThe consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials, European Heart Journal (English Edition), vol.30, 11,pp 1385-1394
2005Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trialsSimes, Robert John; et, al; Granger, Christopher; Labinaz, Marino; Lincoff, A. Michael; Mathias, Jasmine; Moliterno, David J.; Pieper, Karen; Simoons, Maarten L.; Van de Werf, Frans; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials CentreOutcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials, European Heart Journal (2005), vol.26,(2),2005,pp 128-136
2002Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trialsSimes, Robert John; Armstrong, Paul W; Boersma, Eric; Califf, Robert M; Harrington, Robert A; Moliterno, David J; Simoons, Maarten L.; Theroux, Pierre; Topol, Eric J; Torbal, Anneke de; Van de Werf, Frans; Wallentin, Lars C; White, Harvey D; Wilcox, Robert G; School of Public Health: NH&MRC Clinical Trials CentrePlatelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials, The Lancet, vol.359,(9302),2002,pp 189-198
2004Risk Factors For Intracranial Hemorrhage And Nonhemorrhagic Stroke After Fibrinolytic Therapy (From The Gusto-I Trial).Simes, Robert John; Califf, Robert M; Gore, Joel M.; Granger, Christopher; Kandzari, David E; Lee, Kerry L; Longstreth, William T; Mahaffey, Kenneth W; Simoons, Maarten L.; Stebbins, Amanda; Topol, Eric J; Weaver, W Douglas; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials CentreRisk Factors For Intracranial Hemorrhage And Nonhemorrhagic Stroke After Fibrinolytic Therapy (From The Gusto-I Trial)., The American Journal of Cardiology, vol.93,(4),2004,pp 458-461
2002Sustained ventricular arrythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors and outcomesSimes, Robert John; Al-Khatib, Sana M; Armstrong, Paul W; Califf, Robert M; Granger, Christopher B; Harrington, Robert A; Huang, Yao; Lee, Kerry L; Moliterno, David J; Simoons, Maarten L.; Topol, Eric J; Van de Werf, Frans; White, Harvey D; School of Public Health: NH&MRC Clinical Trials CentreSustained ventricular arrythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors and outcomes, Circulation (Baltimore), vol.106,(3),2002,pp 309-312
2017The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS TrialsChalmers, John; MacMahon, Stephen William; Bertrand, Michel; Boersma, Eric; Brugts, Jasper; Ferrari, Roberto; Fox, Keith; Remme, W.; Simoons, Maarten L.; The George Institute for Global Health; The George Institute for Global HealthThe Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials, Cardiovascular Drugs and Therapy, vol.31, 4, 2017,pp 391-400